| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows (used in) provided by investing activities | -70,851 | -26,139 |
| Issuance of common stock and warrants, net | 83,733 | 32,558 |
| Exercise of options | 1 | - |
| Net cash flows provided by financing activities | 83,734 | 32,558 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 3,595 | 972 |
| Cash and cash equivalents at beginning of period | 3,163 | - |
| Cash and cash equivalents at end of period | 6,758 | - |
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)